AU2908501A - Combination therapy for the treatment of inflammatory and respiratory diseases - Google Patents
Combination therapy for the treatment of inflammatory and respiratory diseasesInfo
- Publication number
- AU2908501A AU2908501A AU29085/01A AU2908501A AU2908501A AU 2908501 A AU2908501 A AU 2908501A AU 29085/01 A AU29085/01 A AU 29085/01A AU 2908501 A AU2908501 A AU 2908501A AU 2908501 A AU2908501 A AU 2908501A
- Authority
- AU
- Australia
- Prior art keywords
- inflammatory
- treatment
- combination therapy
- respiratory diseases
- respiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4866—Protein C (3.4.21.69)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17475600P | 2000-01-06 | 2000-01-06 | |
US60174756 | 2000-01-06 | ||
PCT/US2000/034261 WO2001049315A1 (en) | 2000-01-06 | 2000-12-22 | Combination therapy for the treatment of inflammatory and respiratory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2908501A true AU2908501A (en) | 2001-07-16 |
Family
ID=22637397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU29085/01A Abandoned AU2908501A (en) | 2000-01-06 | 2000-12-22 | Combination therapy for the treatment of inflammatory and respiratory diseases |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1251868A1 (en) |
JP (1) | JP2003519196A (en) |
KR (1) | KR20020063298A (en) |
AU (1) | AU2908501A (en) |
WO (1) | WO2001049315A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2463655A1 (en) | 2001-10-15 | 2003-04-24 | Chiron Corporation | Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
NZ536796A (en) * | 2002-04-25 | 2007-03-30 | Scripps Research Inst | Treatment and prevention of pulmonary conditions comprising at least one lung surfactant polypeptide and at least one protease inhibitor, lipase inhibitor or an anti-oxidant |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340191C (en) * | 1988-06-13 | 1998-12-15 | Katsuhiro Imaki | Derivatives of p-substituted phenyl ester of pivalic acid |
JP3434326B2 (en) * | 1992-08-25 | 2003-08-04 | 財団法人化学及血清療法研究所 | Agent for prevention and treatment of adult respiratory distress syndrome (ARDS) |
-
2000
- 2000-12-22 JP JP2001549682A patent/JP2003519196A/en not_active Withdrawn
- 2000-12-22 WO PCT/US2000/034261 patent/WO2001049315A1/en not_active Application Discontinuation
- 2000-12-22 EP EP00993687A patent/EP1251868A1/en not_active Withdrawn
- 2000-12-22 KR KR1020027008745A patent/KR20020063298A/en not_active Application Discontinuation
- 2000-12-22 AU AU29085/01A patent/AU2908501A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2003519196A (en) | 2003-06-17 |
WO2001049315A1 (en) | 2001-07-12 |
EP1251868A1 (en) | 2002-10-30 |
KR20020063298A (en) | 2002-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL169338A0 (en) | Therapeutic formulations for the treatment of beta-amyloid related diseases | |
AU7186501A (en) | Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases | |
PL362711A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
AU2001247331A1 (en) | Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders | |
AU2003264282A1 (en) | Phenethanolamine derivatives and their use in the treatment of respiratory diseases | |
IL196301A0 (en) | Medicament for the treatment of hapatitis c | |
AU1227302A (en) | System and method for optimizing drug therapy for the treatment of diseases | |
ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
EP1392292A4 (en) | Pyranoindazoles and their use for the treatment of glaucoma | |
AU6083899A (en) | Combination of c1-inh and lung surfactant for the treatment of respiratory disorders | |
GB0004531D0 (en) | The treatment of respiratory diseases | |
HUP0302718A3 (en) | Methods and compositions for the treatment of diseases of the eye | |
AU5937901A (en) | Combination therapy of respiratory diseases using antibodies | |
AUPQ344799A0 (en) | Treatment of respiratory diseases and infections | |
IL155174A0 (en) | Methods and compositions for the treatment of inflammatory diseases | |
AU2001249262A1 (en) | Therapeutic compounds for the treatment of asthma and allergy, and methods of use thereof | |
AU2908501A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU5611701A (en) | Agent for the diagnosis and therapy of viral diseases | |
AU2728301A (en) | Combination therapy for the treatment of inflammatory and respiratory diseases | |
AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU1405001A (en) | Treatment of diseases | |
AU2001255168A1 (en) | Compositions and methods for the treatment of immune related diseases | |
AU2002224905A1 (en) | Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |